[1]
2023. Evaluation of Rezum therapy as a minimally invasive modality for management of Benign Prostatic Hyperplasia: A prospective observational study. Archivio Italiano di Urologia e Andrologia. 95, 4 (Dec. 2023). DOI:https://doi.org/10.4081/aiua.2023.12026.